Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-02-09

FDA Approved: RAMELTEON — Original Application (Micro Labs Limited)

View source ↗

Summary

FDA approved an Abbreviated New Drug Application for ramelteon from Micro Labs Limited, establishing a generic version of the insomnia drug ramelteon.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ramelteon (ramelteon)

Snippet

ORIG AP for RAMELTEON (RAMELTEON)